Related Experiment Video
Updated: Jun 22, 2026

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
Published on: July 5, 2017
Effect of Low-Load Blood-Flow Restricted Training Versus Heavy Slow Resistance Training in Unilateral Patellar
Mikkel Holm Hjortshoej1,2,3,4, Hemant Juneja4, René Brüggebusch Svensson1,2,5
1Department of Orthopedic Surgery, Institute of Sports Medicine Copenhagen, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark.
Abstract:
Patellar tendinopathy (PT) is a debilitating overuse injury, and one of the current recommended treatments is heavy slow resistance training (HSRT); Recently, low-load resistance training combined with blood flow restriction (LL-BFRT) has been advocated as a clinically relevant rehabilitation tool for PT since it does not involve large joint and tissue stresses and may accelerate recovery. This study aimed to investigate the effect of LL-BFRT compared with HSRT at 3, 6, 12 (primary endpoint), and 52 weeks. Participants with chronic unilateral PT were randomized to a 12-week rehabilitation program based on either LL-BFRT (n = 16) or HSRT (n = 20). The primary outcome was pain (numerical rating scale (NRS) 0-10) during a single-leg decline squat (SLDS). Secondary outcome variables included the Victorian Institute of Sports Assessment-Patella questionnaire (VISA-P), maximal isometric knee extensor strength, patellar tendon morphology assessed by ultrasonography (swelling, vascularization), and magnetic resonance imaging (MRI). Comparable clinically relevant improvements in pain (NRS during SLDS, least squares mean ± SEM) were observed in LL-BFRT (LL-BFRT: 0 weeks 3.9 ± 0.5, 12 weeks 2.2 ± 0.5, 52 weeks 1.8 ± 0.5) and HSRT (0 weeks 4.2 ± 0.4, 12 weeks 2.2 ± 0.4, 52 weeks 1.1 ± 0.5) (p < 0.0001). Likewise, clinically relevant improvements were reported on the VISA-P score. LL-BFRT and HSRT resulted in comparable short-term and long-term clinical improvements in males with chronic PT. These data advocate that LL-BFRT represents an effective rehabilitation tool in the treatment of chronic PT, while preventing high joint and tendon loads. Trial Registration: Clinicaltrials.org (NCT04550013).

